IRONWOOD PHARMACEUTICALS, INC. Restructuring Reserve, Current
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Restructuring Reserve, Current of $101.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveCurrent · last filed 2026-08-06
- 2026-06-30: Restructuring Reserve, Current $101.00K.
- 2026-03-31: Restructuring Reserve, Current $299.00K.
- 2025-12-31: Restructuring Reserve, Current $771.00K.
- 2025-09-30: Restructuring Reserve, Current $2.55M.
| Period end | Restructuring Reserve, Current | Restructuring Reserve, Current as first filed |
|---|---|---|
| 2026-06-30 | $101.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $299.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $771.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $2.55M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $4.37M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $12.33M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $560.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $3.11M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $4.41M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.96M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $8.30M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $8.61M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $9.23M 10-Q · filed 2023-08-09 | |
| 2021-12-31 | $462.00K 10-K · filed 2023-02-16 | |
| 2021-09-30 | $948.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $2.12M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $5.47M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $10.51M 10-K · filed 2022-02-18 | |
| 2020-03-31 | $200.00K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $179.00K 10-K · filed 2021-02-17 | |
| 2019-09-30 | $432.00K 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $1.60M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $2.96M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $2.88M 10-K · filed 2020-02-13 | $3.30M 10-K · filed 2019-02-25 |
| 2018-09-30 | $7.85M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $2.31M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $1.16M 10-Q · filed 2018-05-04 | |
| 2014-09-30 | $101.00K 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $373.00K 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $1.50M 10-Q · filed 2014-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |